Gara Jalqabaatti › Dhukkuba Kroonii › Missouri › St. Louis
Qorannoo klinikaalii Dhukkuba Kroonii St. Louis, MO keessatti
Qorannoo 19 Dhukkuba Kroonii f St. Louis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 2
- Specialists In Gastroenterology /ID# 283939, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- fi 1 dabalataa
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Namoota walitti qabaa jiraSadarkaa 3
- Washington University School of Medicine ( Site 5058), St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Namoota walitti qabaa jiraSadarkaa 4
- SSM Health Medical Group, Bridgeton · Miili 15 fagaatti
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Washington University /ID# 266938, St Louis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Washington University School of Medicine, St Louis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Washington University School of Medicine-Site Number: 8400075, St Louis
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Namoota walitti qabaa jiraSadarkaa 3
- Washington University School of Medicine, St Louis
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- SSM Health DePaul Hospital- St. Louis, Bridgeton · Miili 15 fagaatti
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- KAD Clinical Research, St Louis
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 4
- Washington University School of Medicine, St Louis
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Washington University, St. Louis, St Louis
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Washington University School of Medicine, St Louis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Investigational Site Number: 8400013, St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Namoota walitti qabaa jiraSadarkaa 2
- Mirador Therapeutics Selected Site, Bridgeton · Miili 15 fagaatti
Treatment of Moderate to Severe Refractory Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 1/2
- Washington University in St. Louis, St Louis
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Namoota walitti qabaa jiraQorannoo ilaalaa
- Washington University in St Louis School of Medicine, St Louis
Qorannoo Dhukkuba Kroonii magaalota biroo keessatti
- New York City, NYQorannoo 35
- Boston, MAQorannoo 19
- Miami, FLQorannoo 19
- Cleveland, OHQorannoo 19
- Tyler, TXQorannoo 17
- Houston, TXQorannoo 17
- Orlando, FLQorannoo 17
- Atlanta, GAQorannoo 17
- San Antonio, TXQorannoo 15
- San Diego, CAQorannoo 15
- Los Angeles, CAQorannoo 15
- Colorado Springs, COQorannoo 13
Qorannoo biroo St. Louis keessatti
- Kansara Qara'a Non-Small CellQorannoo 73
- Saree OljooQorannoo 64
- Kansara MetastatikiiQorannoo 54
- Kansarii ColorectalQorannoo 50
- Saree (Gosoota Hunda)Qorannoo 46
- Kansarii ProstateQorannoo 46
- Dhibee QaraQorannoo 39
- Kansarii OvariiQorannoo 38
- Kansarii PancreasQorannoo 33
- Kansa EndometiriyaaliiQorannoo 29
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 28
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.